Financial statements Goldpharm
Balance sheet data of GOLDPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 830 094,66 | 940 130,03 | 2 027 787,61 | 1 856 494,11 | 2 217 128,52 | 2 598 649,68 |
| A. Fixed assets | 20 346,64 | 7 768,60 | 3 274,04 | 13 054,54 | 9 501,71 | 5 948,88 |
| B. Current assets | 809 748,02 | 932 361,43 | 2 024 513,57 | 1 843 439,57 | 2 207 626,81 | 2 592 700,80 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 830 094,66 | 940 130,03 | 2 027 787,61 | 1 856 494,11 | 2 217 128,52 | 2 598 649,68 |
| A. Equity | 169 698,08 | 295 670,98 | 292 112,58 | 295 491,66 | 456 847,18 | 257 155,56 |
| B. Liabilities and provisions for liabilities | 660 396,58 | 644 459,05 | 1 735 675,03 | 1 561 002,45 | 1 760 281,34 | 2 341 494,12 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.